Newest first. 5.2k questions across 107 tags.
Concretely: BCH · GL Biochem (Shanghai). Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints are…
Details up front: SURMOUNT-2 · tirzepatide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The lane and the lead time matter as much as the material for what I am doing. I would rather over-plan the first cycle and simplify later. I am prepared to do the…
Numbers first: a 29G needle · dulaglutide · 3.33 mg/mL. I have used one of these for a while and I am considering switching, which requires a reason. What I care…
Setup, so nobody has to ask: cagrilintide · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care…
Concretely: an ammonium formate mobile phase · liraglutide · a C8 column. This is one of those things that everyone repeats and nobody derives. This matters…
The case in front of me: a 30G needle · tirzepatide · 6.67 mg/mL. These are treated as interchangeable and I do not think they are. If both are acceptable I would…
The case in front of me: ecnoglutide · minus 20 °C. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
What I have: oral semaglutide · ten days. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator…
I have been on a stable schedule for eleven weeks, so this is not a first-week question. I have the document in front of me and I can read the numbers. What I cannot…
What I have: method section · HJ. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable with…
For reference: tirzepatide · a wide-pore C18 column · liraglutide. I am trying to choose between two options that are usually discussed as though only one exists. I…
Concretely: Xi’an · the Netherlands. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
For reference: 3.33 mg/mL · ecnoglutide. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for…
The particulars: reflux · semaglutide · STEP 1. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
I have the full paper rather than the abstract, and the supplementary appendix. I understand the observation; what I do not understand is the mechanism behind it. I…
The specifics, since they change the answer: dizziness · tirzepatide · SURPASS-2. I have the document in front of me and I can read the numbers. What I cannot do is…
Setup, so nobody has to ask: orforglipron · 12 mg. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of…
Setup, so nobody has to ask: orforglipron · two weeks · 37 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
Stated plainly: WXT · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Concretely: SURMOUNT-OSA · reflux. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do not…
Setup, so nobody has to ask: a residual-solvent screen · cagrilintide. I suspect the honest answer is that it depends, in which case I would like to know on what.…
What I am working with: dizziness · semaglutide · SELECT. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at…
Numbers first: cagrilintide · 6.67 mg/mL. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…